trial

Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia

NCTId NCT00712660
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 146 (actual)
Sponsored by Prague Psychiatric Center
Primary completion 2009-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
146 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2008-11
Primary completion
2009-11
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
antipsychotic dose increase

Sponsors

Prague Psychiatric CenterLead Sponsor
Eli Lilly and CompanyCollaborator

Investigators

1
Filip Spaniel, M.D., PhD.,Principal Investigator

Sites

1 total
Prague, Czechia

Facts & assertions

4 sourced
Enrollment
146
Phase
NA
Primary Completion Date
2009-11
Status
COMPLETED
relationships
The graph out of here
drug
antipsychotic dose increase
drug
lead_sponsor
Prague Psychiatric Center
company
collaborator
Eli Lilly and Company
company
indication
Schizophrenia
indication
Schizophrenia
indication
Recurrence
indication
investigator
Filip Spaniel, M.D., PhD.,
person